Header Logo

Connection

Katya Corado to Emtricitabine

This is a "connection" page, showing publications Katya Corado has written about Emtricitabine.
Connection Strength

0.687
  1. Emtricitabine + tenofovir alafenamide for the treatment of HIV. Expert Opin Pharmacother. 2017 Mar; 18(4):427-432.
    View in: PubMed
    Score: 0.542
  2. Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study. J Acquir Immune Defic Syndr. 2022 12 15; 91(5):453-459.
    View in: PubMed
    Score: 0.051
  3. Pre-Exposure Prophylaxis Perspectives, Sociodemographic Characteristics, and HIV Risk Profiles of Cisgender Women Seeking and Initiating PrEP in a US Demonstration Project. AIDS Patient Care STDS. 2021 12; 35(12):481-487.
    View in: PubMed
    Score: 0.047
  4. Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States. Clin Infect Dis. 2021 10 05; 73(7):1149-1156.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.